MedPath

Safety and Efficacy of Using HDH Device and Method - a Novel Sutureless Vascular Anastomosis

Not Applicable
Completed
Conditions
Vascular Disease
Atherosclerosis
Interventions
Device: HDH
Registration Number
NCT00805831
Lead Sponsor
HDH Medical Ltd
Brief Summary

The HDH device is intended for creating sutureless vascular anastomosis in various blood vessels. The HDH device consists of four parts: an elastic tube (graft), docking head (anastomotic device), inversion device (connects the vascular graft to HDH) and measuring device. This study was design in order to evaluate the safety and efficacy of using HDH device and method an innovative anastomotic device for sutureless aortic anastomosis in patient diagnosed with abdominal aneurysm or Aorto-iliac aneurysm.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
10
Inclusion Criteria
  • Patient age above 18 (men and woman)
  • Patient suffers from infrarenal abdominal aortic or Aorto-iliac aneurysm
  • Aneurysm diameter is larger than 5cm/ its annual growth is more than 0.5cm/or iliac aneurysm size is larger than 2.5cm
  • The abdominal aneurysm neck is longer than 1.5 cm
  • Patient's physical condition allows performing general anesthesia
  • Patient is willing to sign the informed consent and follow the study protocol.
Exclusion Criteria
  • Patient Age under 18 years
  • Patient's physical condition dose not allows to perform general anesthesia
  • Patient's with terminal disease and life expectancy of less than 3 months
  • Patient objects to the treatment or study protocol
  • Anesthesiologist or personal care physician object
  • Patient suffer from Supra/infrarenal AAA
  • The abdominal aneurysm neck is smaller than 1.5 cm
  • Aneurysm diameter is smaller than 5cm/ its annual growth is less than 0.5cm/

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
AHDHAortic anastomosis surgery will be conducted using HDH device.
Primary Outcome Measures
NameTimeMethod
To establish safety of using the HDH device for creating sutureless aortic anastomosis. Safety will be established by lack of serious adverse events.within 1 month
Secondary Outcome Measures
NameTimeMethod
Time to complete the anastomosisduring the surgery

Trial Locations

Locations (1)

Barzilai Medical center

🇮🇱

Ashkelon, Israel

© Copyright 2025. All Rights Reserved by MedPath